High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma

Br J Dermatol. 2024 Jul 16;191(2):295-296. doi: 10.1093/bjd/ljae171.
No abstract available

Publication types

  • Letter

MeSH terms

  • 5-Methylcytosine* / analogs & derivatives
  • 5-Methylcytosine* / metabolism
  • Aged
  • Aged, 80 and over
  • Female
  • Histiocytoma, Benign Fibrous / diagnosis
  • Histiocytoma, Benign Fibrous / pathology
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local* / prevention & control
  • Sarcoma / pathology
  • Skin Neoplasms* / pathology

Substances

  • 5-Methylcytosine
  • 5-hydroxymethylcytosine